Divi's Laboratories Limited (DIVISLAB)

Name: Divi's Laboratories Limited (DIVISLAB) — historique des états financiers
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Historique du chiffre d'affaires, des bénéfices et des flux de trésorerie d'après les états financiers officiels.

Healthcare · Wall Street (États-Unis) · Dernière mise à jour : 2026-09-20

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products.

Chiffres clés

Capitalisation boursière: ₹2.49 trillion
Chiffre d'affaires (exercice clos en 2026-03-31): ₹104.8B
Résultat net: ₹25.7B
Marge brute: 59.1%
Marge nette: 24.5%

Voir les graphiques interactifs et les états complets →

Compte de résultat annuel

Compte de résultat	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Chiffre d'affaires total	₹104.8B	₹93.2B	₹78.0B	₹76.7B
Bénéfice brut	₹62.0B	₹54.5B	₹45.3B	₹44.9B
Résultat opérationnel (EBIT)	₹29.8B	₹25.7B	₹18.3B	₹20.3B
Résultat net	₹25.7B	₹21.9B	₹16.0B	₹18.2B

Source : rapports publics de la société (SEC). Vérifiez sur SEC EDGAR avant de vous fier à tout chiffre.

Bilans, flux de trésorerie, données trimestrielles et ratios complets dans le visualiseur interactif de DIVISLAB. /companies/us/DIVISLAB

Entreprises similaires

Les informations de ce site sont fournies à des fins éducatives et informatives uniquement ; elles ne constituent pas un conseil en investissement. Aucun objectif de cours ni recommandation n'est publié.

English version →Toutes les actions

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.